The Effect of Horticultural Therapy on Stress, Well-Being, and Care Burden in Hemodialysis Caregivers

NCT07188792 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 82

Last updated 2025-09-23

No results posted yet for this study

Summary

This research is a randomized controlled single-blind experimental study aiming to evaluate the effect of horticultural therapy on stress, well-being, and caregiver burden among caregivers of hemodialysis patients. The study will be conducted between April-July 2025 with caregivers of patients receiving hemodialysis treatment at Bingöl State Hospital. The sample of the study will consist of 82 caregivers, randomly assigned into experimental and control groups. After obtaining verbal and written consents from all participants, the Introductory Information Form, Perceived Stress Scale, General Well-Being Scale, and Zarit Burden Interview will be applied as pre-test. The experimental group will participate in horticultural therapy activities once a week for 12 weeks, while no intervention will be given to the control group during this period. Following the intervention, post-test measurements will be administered to both groups using the same instruments. In addition, feedback will be collected from caregivers in the experimental group regarding the research process. After the study is completed, the same intervention will also be offered to the control group to ensure ethical responsibility. Data obtained will be analyzed using SPSS 22.00 package program. Ethical principles will be observed throughout the study, ethics committee approval has been obtained, and the Helsinki Declaration of Human Rights will be adhered to. The results are planned to be presented at an international congress and published in an SCI/SSCI-indexed journal, contributing to the scientific literature.

Conditions

  • Hemodialysis Patients

Interventions

OTHER

HORTICULTURAL THERAPY

* Introduction * Explanation of the training content for horticultural activities using visual materials * Explanation of the program's scope, duration, and expected participant roles and responsibilities

Sponsors & Collaborators

  • Ataturk University

    lead OTHER

Principal Investigators

  • DİLEK KILIÇ · Ataturk University

  • GÜLNAZ ATA · TOKAT GAZİOSMANPAŞA UNIVERSITY

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-09-01
Primary Completion
2025-03-01
Completion
2025-10-01

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07188792 on ClinicalTrials.gov